Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d’Ivoire, 2023: A Secondary Analysis
Prices of antidiabetic drugs were higher than the international references prices. The development of a pricing policy emphasizing added value and price referencing, together with the development of a local generics industry, could guarantee prices that are accessible to the population and bearable by universal health coverage.
Authors
- Kouamé Koffi (ORCID: https://orcid.org/0000-0002-2146-9110)
- Julie Sackou-Kouakou (ORCID: https://orcid.org/0000-0002-4718-4084)
- A.R. Attia-Konan (ORCID: https://orcid.org/0000-0003-1790-2767)
- Emeline Annita Hounsa Alla
- Anicet Jean Marc Sindé
Institutions
- Health Information Management (BE)
- Institut National d’Hygiène Publique (CI)
- Université Félix Houphouët-Boigny (CI)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/ceor.s548459
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13